Latest Insider Transactions at Elanco Animal Health Inc (ELAN)
This section provides a real-time view of insider transactions for Elanco Animal Health Inc (ELAN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Elanco Animal Health Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Elanco Animal Health Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 27
2024
|
De Simas Jose Manuel Correia |
SELL
Payment of exercise price or tax liability
|
Direct |
4,044
-8.55%
|
$64,704
$16.46 P/Share
|
|
Feb 27
2024
|
De Simas Jose Manuel Correia |
BUY
Grant, award, or other acquisition
|
Direct |
8,610
+15.4%
|
-
|
|
Feb 27
2024
|
Ellen De Brabander |
SELL
Payment of exercise price or tax liability
|
Direct |
12,060
-11.5%
|
$192,960
$16.46 P/Share
|
|
Feb 27
2024
|
Ellen De Brabander |
BUY
Grant, award, or other acquisition
|
Direct |
24,362
+18.85%
|
-
|
|
Jan 03
2024
|
Grace Mc Ardle EVP, MANUFACTURING AND QUALITY |
SELL
Payment of exercise price or tax liability
|
Direct |
626
-1.48%
|
$8,764
$14.37 P/Share
|
|
Jan 03
2024
|
James M Meer CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
402
-0.96%
|
$5,628
$14.37 P/Share
|
|
Nov 30
2023
|
Deborah Turner Kochevar |
BUY
Grant, award, or other acquisition
|
Direct |
20,374
+24.97%
|
-
|
|
Nov 30
2023
|
Lawrence Erik Kurzius |
BUY
Grant, award, or other acquisition
|
Direct |
20,374
+21.75%
|
-
|
|
Nov 30
2023
|
John P Bilbrey |
BUY
Grant, award, or other acquisition
|
Direct |
20,374
+25.28%
|
-
|
|
Nov 30
2023
|
Kirk P Mc Donald |
BUY
Grant, award, or other acquisition
|
Direct |
20,374
+25.28%
|
-
|
|
Nov 30
2023
|
Denise Scots Knight |
BUY
Grant, award, or other acquisition
|
Direct |
20,374
+25.28%
|
-
|
|
Nov 30
2023
|
Art A Garcia |
BUY
Grant, award, or other acquisition
|
Direct |
20,374
+24.5%
|
-
|
|
Nov 30
2023
|
William F Doyle |
BUY
Grant, award, or other acquisition
|
Direct |
20,374
+30.54%
|
-
|
|
Nov 30
2023
|
Paul Herendeen |
BUY
Grant, award, or other acquisition
|
Direct |
20,374
+26.56%
|
-
|
|
Nov 30
2023
|
Kapila K Anand |
BUY
Grant, award, or other acquisition
|
Direct |
20,374
+23.46%
|
-
|
|
Nov 30
2023
|
R David Hoover |
BUY
Grant, award, or other acquisition
|
Direct |
20,374
+20.65%
|
-
|
|
Nov 30
2023
|
Michael J Harrington |
BUY
Grant, award, or other acquisition
|
Direct |
20,374
+21.48%
|
-
|
|
Nov 01
2023
|
Ellen De Brabander |
SELL
Payment of exercise price or tax liability
|
Direct |
11,295
-12.3%
|
$90,360
$8.63 P/Share
|
|
Jul 03
2023
|
James M Meer CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,977
+16.04%
|
-
|
|
Jul 03
2023
|
Grace Mc Ardle EVP, MANUFACTURING AND QUALITY |
BUY
Grant, award, or other acquisition
|
Direct |
19,941
+32.03%
|
-
|
|
Jul 01
2023
|
Marcela A. Kirberger |
SELL
Payment of exercise price or tax liability
|
Direct |
1,868
-3.82%
|
$18,680
$10.06 P/Share
|
|
Jul 01
2023
|
De Simas Jose Manuel Correia |
SELL
Payment of exercise price or tax liability
|
Direct |
2,239
-5.47%
|
$22,390
$10.06 P/Share
|
|
Apr 03
2023
|
Timothy J Bettington |
BUY
Grant, award, or other acquisition
|
Direct |
108,109
+50.0%
|
-
|
|
Apr 01
2023
|
Rajeev A. Modi |
SELL
Payment of exercise price or tax liability
|
Direct |
7,508
-11.31%
|
$67,572
$9.4 P/Share
|
|
Mar 15
2023
|
Todd S. Young |
BUY
Bona fide gift
|
Indirect |
4,000
+50.0%
|
-
|
|
Mar 15
2023
|
Todd S. Young |
SELL
Bona fide gift
|
Indirect |
4,000
-1.71%
|
-
|
|
Mar 14
2023
|
Todd S. Young |
BUY
Bona fide gift
|
Indirect |
118,309
+50.0%
|
-
|
|
Mar 14
2023
|
Todd S. Young |
SELL
Bona fide gift
|
Direct |
118,309
-57.37%
|
-
|
|
Mar 14
2023
|
R David Hoover |
BUY
Open market or private purchase
|
Indirect |
5,000
+2.94%
|
$45,000
$9.55 P/Share
|
|
Mar 13
2023
|
R David Hoover |
BUY
Open market or private purchase
|
Indirect |
5,000
+3.03%
|
$45,000
$9.46 P/Share
|
|
Mar 10
2023
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
BUY
Open market or private purchase
|
Indirect |
15,000
+25.0%
|
$135,000
$9.6 P/Share
|
|
Mar 05
2023
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
10,696
-0.93%
|
$117,656
$11.1 P/Share
|
|
Mar 03
2023
|
R David Hoover |
BUY
Open market or private purchase
|
Indirect |
10,000
+6.06%
|
$110,000
$11.13 P/Share
|
|
Mar 02
2023
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
147,031
-5.8%
|
$1,617,341
$11.01 P/Share
|
|
Mar 02
2023
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
316,386
+19.68%
|
-
|
|
Mar 02
2023
|
David S Kinard |
SELL
Payment of exercise price or tax liability
|
Direct |
13,428
-4.81%
|
$147,708
$11.01 P/Share
|
|
Mar 02
2023
|
David S Kinard |
BUY
Grant, award, or other acquisition
|
Direct |
28,571
+16.74%
|
-
|
|
Mar 02
2023
|
David Alan Urbanek |
SELL
Payment of exercise price or tax liability
|
Direct |
15,561
-5.35%
|
$171,171
$11.01 P/Share
|
|
Mar 02
2023
|
David Alan Urbanek |
BUY
Grant, award, or other acquisition
|
Direct |
33,502
+18.47%
|
-
|
|
Mar 02
2023
|
De Simas Jose Manuel Correia |
SELL
Payment of exercise price or tax liability
|
Direct |
6,801
-14.24%
|
$74,811
$11.01 P/Share
|
|
Mar 02
2023
|
De Simas Jose Manuel Correia |
BUY
Grant, award, or other acquisition
|
Direct |
15,107
+24.04%
|
-
|
|
Mar 02
2023
|
James M Meer CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,797
-2.7%
|
$19,767
$11.01 P/Share
|
|
Mar 02
2023
|
James M Meer CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,659
+19.74%
|
-
|
|
Mar 02
2023
|
Todd S. Young |
SELL
Payment of exercise price or tax liability
|
Direct |
31,249
-6.82%
|
$343,739
$11.01 P/Share
|
|
Mar 02
2023
|
Todd S. Young |
BUY
Grant, award, or other acquisition
|
Direct |
66,655
+22.08%
|
-
|
|
Mar 02
2023
|
Ramiro Martin Cabral |
SELL
Payment of exercise price or tax liability
|
Direct |
18,887
-6.21%
|
$207,757
$11.01 P/Share
|
|
Mar 02
2023
|
Ramiro Martin Cabral |
BUY
Grant, award, or other acquisition
|
Direct |
40,423
+20.64%
|
-
|
|
Mar 01
2023
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
248,668
+20.06%
|
-
|
|
Mar 01
2023
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
12,662
-1.68%
|
$139,282
$11.26 P/Share
|
|
Mar 01
2023
|
Ramiro Martin Cabral |
BUY
Grant, award, or other acquisition
|
Direct |
37,745
+24.36%
|
-
|